Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/177005
Title: | Obesity attenuates the effect of sleep apnea on active TGF-ss 1 levels and tumor aggressiveness in patients with melanoma |
Author: | Cubillos Zapata, Carolina Martínez García, Miguel Ángel Díaz García, Elena Jaureguizar, Ana Campos Rodríguez, Francisco Sánchez de la Torre, Manuel Nagore, Eduardo Martorell Calatayud, Antonio Hernández Blasco, Luis Pastor, Esther Abad Capa, Jorge Montserrat Canal, José Ma. Cabriada Nuño, Valentín Cano Pumarega, Irene Corral Peñafiel, Jaime Arias, Eva Mediano, Olga Somoza González, María Dalmau Arias, Joan Almendros López, Isaac Farré Ventura, Ramon López Collazo, Eduardo Gozal, David Garcií Río, Francisco |
Keywords: | Anoxèmia Obesitat Síndromes d'apnea del son Anoxemia Obesity Sleep apnea syndromes |
Issue Date: | 23-Sep-2020 |
Publisher: | Nature Publishing Group |
Abstract: | Active transforming growth factor-β1 (TGF-β1), a cytokine partially regulated by hypoxia and obesity, has been related with poor prognosis in several tumors. We determine whether obstructive sleep apnea (OSA) increases serum levels of active TGF-β1 in patients with cutaneous melanoma (CM), assess their relationship with melanoma aggressiveness and analyze the factors related to TGF-β1 levels in obese and non-obese OSA patients. In a multicenter observational study, 290 patients with CM were underwent sleep studies. TGF-β1 was increased in moderate-severe OSA patients vs. non-OSA or mild OSA patients with CM. In OSA patients, TGF-β1 levels correlated with mitotic index, Breslow index and melanoma growth rate, and were increased in presence of ulceration or higher Clark levels. In CM patients, OSA was associated with higher TGF-β1 levels and greater melanoma aggressiveness only in non-obese subjects. An in vitro model showed that IH-induced increases of TGF-β1 expression in melanoma cells is attenuated in the presence of high leptin levels. In conclusion, TGF-β1 levels are associated with melanoma aggressiveness in CM patients and increased in moderate-severe OSA. Moreover, in non-obese patients with OSA, TGF-β1 levels correlate with OSA severity and leptin levels, whereas only associate with leptin levels in obese OSA patients. |
Note: | Reproducció del document publicat a: https://doi.org/10.1038/s41598-020-72481-x |
It is part of: | Scientific Reports, 2020, vol. 10, num. 1, p. 15528 |
URI: | http://hdl.handle.net/2445/177005 |
Related resource: | https://doi.org/10.1038/s41598-020-72481-x |
ISSN: | 2045-2322 |
Appears in Collections: | Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) Articles publicats en revistes (Biomedicina) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
708663.pdf | 1.39 MB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License